Could a new drug stop diabetes in six days?
Could dolphins hold the key to curing diabetes?
Researchers have discovered that dolphins have a form of type 2 diabetes, but unlike humans they are able to turn the condition on and off. The discovery opens the door to revolutionary treatments for the disease, and possibly a cure.
Anti-inflammatory drug shows promise for treatment of type 2 diabetes
A new drug study found that people with type 2 diabetes showed improved blood glucose levels and lower A1C scores when salsalate was added to their regular drug regimen. Similar to aspirin but easier on the stomach, salsalate has been used for years as a low-cost treatment for arthritis. The key to the drug’s success in treating type 2 diabetes may lie in its anti-inflammatory properties, which counter the chronic inflammation that comes with weight gain and promotes diabetes.
Study of new Exsulin peptide treatment for type 1 diabetes starts this month
The only way to control type 1 diabetes is through regular insulin injections, but a clinical trial of Exsulin – an innovative new treatment that targets the underlying cause of type 1 diabetes – has begun at the McGill University Health Centre. The study examines weather Exsulin-based treatment can be used to stimulate regrowth of insulin-producing beta cells in diabetic patients. The results of human trials have indicated that Exsulin triggers at least a partial recovery of natural insulin secretion.
Diabetes an epidemic among Canada’s First Nations people
New research shows that type 2 diabetes is much more common among Canada’s First Nations people than their non-native counterparts, and women of childbearing age are particularly at risk.
Furthermore, there’s a “striking difference” in the age at which the two groups develop the disease, according to Dr. Ronald Dyck of the University of Saskatchewan. New cases peak among First Nations people in their 40s, while non-indigenous adults typically develop type 2 diabetes at age 70 or later.
Why Alzheimer’s is called ‘type 3 diabetes’
The role of insulin in the brain and the link between type 2 diabetes and Alzheimer’s is a multi-faceted one. Studies have shown that diabetics have a 30 to 65 percent higher risk of developing Alzheimer’s disease. While both can be age-related diseases, a growing body of research is showing an even stronger link that connect both diabetes and Alzheimer’s: Insulin. So strong is the link, some call Alzheimer’s “type 3 diabetes.”